Immuron (IMRN) Return on Capital Employed (2018 - 2024)
Immuron (IMRN) recorded quarterly Return on Capital Employed of 56732272386237.33% in Q4 2024, up 30885015529.52% quarter-over-quarter from 183688.66% in Q4 2023, and up 5673227256992599.0% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) Return on Capital Employed (2018 - 2024) Analysis & Trends
Immuron's Return on Capital Employed history runs 7 years deep, the most recent figure standing at 56732272386237.33% for Q4 2024.
- In Q4 2024, Return on Capital Employed rose 5673227256992599.0% year-over-year to 56732272386237.33%; the TTM figure through Dec 2024 stood at 56732272386237.33% (up 5673227256992599.0% YoY), while the FY2025 annual figure was 166.05%, down 13738.0% from the prior year.
- Return on Capital Employed was 56732272386237.33% for Q4 2024 at Immuron, up from 183688.66% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 56732272386237.33% in Q4 2024 to a low of 183688.66% in Q4 2023.
- Historically, Return on Capital Employed has averaged 9455378647625.91% across 5 years, with a median of 89613.68% in 2023.
- The sharpest annual moves came in 2021 and 2024: Return on Capital Employed slumped 13758298 bps in 2021, then surged 2000000000 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 8.56% in 2020, then plunged by 1606597 bps to 137574.42% in 2021, then soared by 39 bps to 84234.89% in 2022, then plunged by 118 bps to 183688.66% in 2023, then soared by 2000000000 bps to 56732272386237.33% in 2024.
- The last three Return on Capital Employed figures came in at 56732272386237.33% (Q4 2024), 183688.66% (Q4 2023), and 94992.46% (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 56,732,272,386,237.33% |
| Dec 31, 2023 | -183,688.66% |
| Jun 30, 2023 | -94,992.46% |
| Dec 31, 2022 | -84,234.89% |
| Dec 31, 2021 | -137,574.42% |
| Dec 31, 2020 | 8.56% |
| Dec 31, 2019 | 158.52% |
| Dec 31, 2018 | 49.53% |